ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study
Dipender Gill, Marios Arvanitis, Paul Carter, Ana I. Hernández Cordero, Brian Jo, Ville Karhunen, View ORCID ProfileSusanna C. Larsson, Xuan Li, Sam M. Lockhart, Amy Mason, Evanthia Pashos, Ashis Saha, Vanessa Y. Tan, View ORCID ProfileVerena Zuber, Yohan Bossé, Sarah Fahle, Ke Hao, Tao Jiang, Philippe Joubert, Alan C. Lunt, Willem Hendrik Ouwehand, David J. Roberts, Wim Timens, Maarten van den Berge, Nicholas A. Watkins, Alexis Battle, Adam S. Butterworth, John Danesh, Barbara E. Engelhardt, James E. Peters, Don D. Sin, Stephen Burgess
doi: https://doi.org/10.1101/2020.04.10.20059121
Dipender Gill
1Department of Epidemiology and Biostatistics, Medical School Building, St Mary’s Hospital, Imperial College London, London, UK
Marios Arvanitis
2Department of Medicine, Division of Cardiology, Johns Hopkins University, Baltimore, MD, USA
Paul Carter
3Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Ana I. Hernández Cordero
4The University of British Columbia Centre for Heart Lung Innovation, St Paul’s Hospital, Vancouver, BC, Canada
Brian Jo
5Program in Quantitative and Computational Biology, Lewis Sigler Institute for Integrative Biology, Princeton, NJ, USA
Ville Karhunen
1Department of Epidemiology and Biostatistics, Medical School Building, St Mary’s Hospital, Imperial College London, London, UK
Susanna C. Larsson
6Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
7Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
Xuan Li
4The University of British Columbia Centre for Heart Lung Innovation, St Paul’s Hospital, Vancouver, BC, Canada
Sam M. Lockhart
8Medical Research Council Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK
Amy Mason
9British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
10National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals, Cambridge, UK
Evanthia Pashos
11Internal Medicine Research Unit, Pfizer Worldwide Research, Development & Medical, Cambridge, MA, USA
Ashis Saha
12Department of Computer Science, Johns Hopkins University, Baltimore, MD, USA
Vanessa Y. Tan
13Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, UK
14Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
Verena Zuber
1Department of Epidemiology and Biostatistics, Medical School Building, St Mary’s Hospital, Imperial College London, London, UK
15Medical Research Council Biostatistics Unit, Cambridge Institute of Public Health, University of Cambridge, Cambridge, UK
Yohan Bossé
16Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval, Quebec, Canada
Sarah Fahle
9British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
10National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals, Cambridge, UK
17National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK
Ke Hao
18Department of Genetics and Genomic Sciences, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Tao Jiang
9British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Philippe Joubert
16Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval, Quebec, Canada
Alan C. Lunt
1Department of Epidemiology and Biostatistics, Medical School Building, St Mary’s Hospital, Imperial College London, London, UK
Willem Hendrik Ouwehand
20NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge, UK
21Wellcome Sanger Institute, Cambridge, UK
David J. Roberts
17National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK
22NHS Blood and Transplant-Oxford Centre, Level 2, John Radcliffe Hospital, Oxford, UK
23Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK
Wim Timens
24University of Groningen, Department of Pathology and Medical Biology and Groningen Research Institute for Asthma and COPD, Groningen, the Netherlands
Maarten van den Berge
25University of Groningen, Department of Pulmonology and Groningen Research Institute for Asthma and COPD, Groningen, the Netherlands
Nicholas A. Watkins
17National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK
26Research and Development, NHS Blood and Transplant, Bristol, United Kingdom
Alexis Battle
27Department of Biomedical Engineering and Center for Computational Biology, Johns Hopkins University, Baltimore, MD, USA
Adam S. Butterworth
9British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
10National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals, Cambridge, UK
17National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK
28British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK
29Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK
John Danesh
9British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
10National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals, Cambridge, UK
17National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK
21Wellcome Sanger Institute, Cambridge, UK
28British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK
29Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK
Barbara E. Engelhardt
30Computer Science Department and Center for Statistics and Machine Learning, Princeton University, Princeton, NJ, USA
James E. Peters
29Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK
31Department of Immunology and Inflammation, Faculty of Medicine, Imperial College London, London, UK
Don D. Sin
4The University of British Columbia Centre for Heart Lung Innovation, St Paul’s Hospital, Vancouver, BC, Canada
Stephen Burgess
9British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
10National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals, Cambridge, UK
15Medical Research Council Biostatistics Unit, Cambridge Institute of Public Health, University of Cambridge, Cambridge, UK
28British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK
32Homerton College, University of Cambridge, Cambridge, UK
Article usage
Posted April 14, 2020.
ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study
Dipender Gill, Marios Arvanitis, Paul Carter, Ana I. Hernández Cordero, Brian Jo, Ville Karhunen, Susanna C. Larsson, Xuan Li, Sam M. Lockhart, Amy Mason, Evanthia Pashos, Ashis Saha, Vanessa Y. Tan, Verena Zuber, Yohan Bossé, Sarah Fahle, Ke Hao, Tao Jiang, Philippe Joubert, Alan C. Lunt, Willem Hendrik Ouwehand, David J. Roberts, Wim Timens, Maarten van den Berge, Nicholas A. Watkins, Alexis Battle, Adam S. Butterworth, John Danesh, Barbara E. Engelhardt, James E. Peters, Don D. Sin, Stephen Burgess
medRxiv 2020.04.10.20059121; doi: https://doi.org/10.1101/2020.04.10.20059121
ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study
Dipender Gill, Marios Arvanitis, Paul Carter, Ana I. Hernández Cordero, Brian Jo, Ville Karhunen, Susanna C. Larsson, Xuan Li, Sam M. Lockhart, Amy Mason, Evanthia Pashos, Ashis Saha, Vanessa Y. Tan, Verena Zuber, Yohan Bossé, Sarah Fahle, Ke Hao, Tao Jiang, Philippe Joubert, Alan C. Lunt, Willem Hendrik Ouwehand, David J. Roberts, Wim Timens, Maarten van den Berge, Nicholas A. Watkins, Alexis Battle, Adam S. Butterworth, John Danesh, Barbara E. Engelhardt, James E. Peters, Don D. Sin, Stephen Burgess
medRxiv 2020.04.10.20059121; doi: https://doi.org/10.1101/2020.04.10.20059121
Subject Area
Subject Areas
- Addiction Medicine (115)
- Allergy and Immunology (316)
- Anesthesia (76)
- Cardiovascular Medicine (695)
- Dermatology (79)
- Emergency Medicine (221)
- Epidemiology (7504)
- Gastroenterology (318)
- Genetic and Genomic Medicine (1386)
- Geriatric Medicine (132)
- Health Economics (319)
- Health Informatics (1059)
- Health Policy (540)
- Hematology (157)
- HIV/AIDS (298)
- Medical Education (168)
- Medical Ethics (41)
- Nephrology (159)
- Neurology (1315)
- Nursing (65)
- Nutrition (206)
- Oncology (740)
- Ophthalmology (224)
- Orthopedics (75)
- Otolaryngology (144)
- Pain Medicine (80)
- Palliative Medicine (31)
- Pathology (204)
- Pediatrics (431)
- Primary Care Research (165)
- Public and Global Health (3213)
- Radiology and Imaging (525)
- Respiratory Medicine (439)
- Rheumatology (166)
- Sports Medicine (122)
- Surgery (161)
- Toxicology (33)
- Transplantation (72)
- Urology (56)